Verily Life Sciences
269 E Grand Avenue
South San Francisco
California
94080
United States
Website: https://www.verily.com/
Email: info@verily.com
About Verily Life Sciences
Launched in 2015, Verily is a subsidiary of Alphabet focused on life sciences and healthcare. Verily’s mission is to make the world’s health data useful so that people enjoy longer and healthier lives. Verily develops tools and devices to collect, organize and activate health data, and creates interventions to prevent and manage disease. Verily partners with leading life sciences, medical device and government organizations, using deep hardware, software, scientific, and healthcare expertise to enable faster development, meaningful advances, and deployment at scale.
Introducing Verily
69 articles with Verily Life Sciences
-
Venture capital firm Foresite Capital, located in San Francisco, is launching a new fund, its fourth and largest, worth $668 million.
-
Many of the trends that affect biopharma recruitment are trends that affect healthcare in general, as well as other industries.
-
The two companies will use Verity’s Immunoscape platform to profile the molecular characteristics of inflammatory diseases.
-
Gilead and Verily Announce Scientific Collaboration to Identify and Understand Immunological and Molecular Drivers of Inflammatory Diseases
4/30/2018
Gilead Sciences, Inc. and Verily Life Sciences LLC announced a scientific collaboration using Verily’s Immunoscape platform to identify and better understand the immunological basis of three common and serious inflammatory diseases.
-
Glytec Integrates With Onduo Virtual Diabetes Clinic
11/29/2017
The integrated solution will launch in pilot programs with select U.S. providers and payers early 2018.
-
Telcare, a Division of BioTelemetry, Announces Collaboration With Onduo in Diabetes Management Program
11/28/2017
Telcare will serve as the supplier of remote blood glucose systems and the resulting data for patients enrolled in Onduo’s groundbreaking diabetes management program.
-
The opportunity to work at the leading edge of science and technology while working on solutions to some of the world's most vexing problems is what attracts people to Verily.
-
Google's Verily Woos Startups With Lab and Office Space, Talent Access
9/6/2017
-
Google Quietly Invests in This Cancer-Testing Startup, Builds Lab on Verily Campus to Sweeten Deal
7/27/2017
-
Google's Verily Robots Just Released Millions Of Mosquitos In California
7/18/2017
-
Google's Verily Deploys Wearable Electronics for Huge Health Study
7/10/2017
-
Medicxi Launches First $300 Million Late-Stage Life Sciences Fund Medicxi Growth 1 (MG1), Backed By Novartis Animal Health Inc. And Verily
6/15/2017
-
Google's Verily and Novartis AG Jump Into Medicxi's $300 Million Life Science Investment Fund
6/15/2017
-
Spotted in the Bay Area: Former FDA Head in Talks to Join Google's Verily
5/18/2017
-
Google's Verily Scientist Left to Co-Found Stealth Health Startup Named Mindstrong
5/11/2017
-
Google's Verily Headcount Doubled In 2 Years To 500 Employees, But Will It Continue To Be Profitable?
5/11/2017
-
Google's Verily Loses High-Profile Scientist
5/10/2017
-
Verily’s Baseline: Homemade Wearable And Limited Data Sharing
4/20/2017
-
Verily Launches Landmark Study With Duke And Stanford As First Initiative Of Project Baseline
4/20/2017
-
Google's Verily Launches 10,000-Person Study to 'Create a Map of Human Health'
4/19/2017